Cyclin E is a more powerful predictor of breast cancer outcome than proliferation
Nat Med
.
2003 Feb;9(2):152.
doi: 10.1038/nm0203-152.
Authors
Khandan Keyomarsi
,
Susan L Tucker
,
Isabelle Bedrosian
PMID:
12563321
DOI:
10.1038/nm0203-152
No abstract available
Publication types
Comment
Letter
MeSH terms
Biomarkers, Tumor / analysis*
Breast Neoplasms / pathology*
Cell Division*
Cyclin E / analysis*
Prognosis
Substances
Biomarkers, Tumor
Cyclin E